Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A heterogenous group of disorders characterized by alterations of mitochondrial metabolism that result in muscle and nervous system dysfunction. These are often multisystemic and vary considerably in age at onset (usually in the first or second decade of life), distribution of affected muscles, severity, and course. (From Adams et al., Principles of Neurology, 6th ed, pp984-5)
Biomarker and diagnostic research for mitochondrial encephalomyopathy has been reported in the published literature.
3 clinical trials registered, 1 recruiting. Interventions under study include drug therapy. Pipeline includes 1 PHASE3, 2 PHASE2. Research is sponsored by a mix of industry and academic institutions.
106 publications have been identified in PubMed for mitochondrial encephalomyopathy. Research spans Case Report / Case Series (43%), Basic Science / Preclinical (25%), and Epidemiology / Natural History (10%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 46 |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 11:11 AM UTC
Laboratory research | 27 | 25% |
Disease patterns and progression | 11 | 10% |
Research summaries | 8 | 8% |
Clinical study results | 6 | 6% |
Testing and diagnosis research | 5 | 5% |
New treatment approaches | 2 | 2% |
Other research | 1 | 1% |
Zhang X (2026). [PMID: 41539960](https://pubmed.ncbi.nlm.nih.gov/41539960/). *Zhonghua er ke za zhi = Chinese journal of pediatrics*. [Case Report / Case Series]
Zhang W (2026). [PMID: 42024134](https://pubmed.ncbi.nlm.nih.gov/42024134/). *Rev Esp Enferm Dig*. [Basic Science / Preclinical]
Luo X (2026). [PMID: 42079699](https://pubmed.ncbi.nlm.nih.gov/42079699/). *Front Cardiovasc Med*. [Case Report / Case Series]
Nilsén V (2026). [PMID: 41660009](https://pubmed.ncbi.nlm.nih.gov/41660009/). *Frontiers in transplantation*. [Case Report / Case Series]
Banerjee S (2026). [PMID: 41850596](https://pubmed.ncbi.nlm.nih.gov/41850596/). *Mitochondrion*. [Epidemiology / Natural History]
Oppenheimer KR (2026). [PMID: 41472381](https://pubmed.ncbi.nlm.nih.gov/41472381/). *The Journal of clinical endocrinology and metabolism*. [Case Report / Case Series]
Kuwabara T (2026). [PMID: 41686338](https://pubmed.ncbi.nlm.nih.gov/41686338/). *JA clinical reports*. [Case Report / Case Series]
Liu Q (2026). [PMID: 41626228](https://pubmed.ncbi.nlm.nih.gov/41626228/). *Frontiers in medicine*. [Case Report / Case Series]
Shu J (2026). [PMID: 41794663](https://pubmed.ncbi.nlm.nih.gov/41794663/). *BMC neurology*. [Case Report / Case Series]
Kim CH (2026). [PMID: 41069004](https://pubmed.ncbi.nlm.nih.gov/41069004/). *Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology*. [Clinical Trial Publication]